Repair of Osteochondral Lesions - Engineered Bone: Tissue Engineering Intelligence Unit - page 180

42. van den Berg WB, van Osch GJ, van der Kraan PM et al. Cartilage destruction and osteophytes in
instability-induced murine osteoarthritis: Role of TGF beta in osteophyte formation? Agents Ac-
tions 1993; 40(3-4):215-9.
43. Anderson JM, Langone JJ. Issues and perspectives on the biocompatibility and immunotoxicity
evaluation of implanted controlled release systems. J Control Release 1999; 57(2):107-13.
44. Lucas PA, Laurencin C, Syftestad GT et al. Ectopic induction of cartilage and bone by water-soluble
proteins from bovine bone using a polyanhydride delivery vehicle. J Biomed Mater Res 1990;
24(7):901-11.
45. Sellers RS, Peluso D, Morris EA. The effect of recombinant human bone morphogenetic protein-2
(rhBMP-2) on the healing of full-thickness defects of articular cartilage. J Bone Joint Surg Am
1997; 79(10):1452-63.
46. Sakiyama-Elbert SE, Hubbell JA. Development of fibrin derivatives for controlled release of
heparin-binding growth factors. J Control Release 2000; 65(3):389-402.
47. Wee S, Gombotz WR. Protein release from alginate matrices. Adv Drug Deliv Rev 1998;
31(3):267-85.
48. Fraser JR, Laurent TC, Laurent UB. Hyaluronan: Its nature, distribution, functions and turnover.
J Intern Med 1997; 242(1):27-33.
49. Collis L, Hall C, Lange L et al. Rapid hyaluronan uptake is associated with enhanced motility:
Implications for an intracellular mode of action. FEBS Lett 1998; 440(3):444-9.
50. Simon LD, Stella VJ, Charman WN et al. Mechanisms controlling diffusion and release of model
proteins through and from partially esterified hyaluronic acid membranes. J Control Release 1999;
61(3):267-79.
51. Bulpitt P, Aeschlimann D. New strategy for chemical modification of hyaluronic acid: Preparation
of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J
Biomed Mater Res 1999; 47(2):152-69.
52. Shastri VP, Martin I, Langer R. Macroporous polymer foams by hydrocarbon templating. Proc
Natl Acad Sci USA 2000; 97(5):1970-5.
53. Saito N, Okada T, Horiuchi H et al. A biodegradable polymer as a cytokine delivery system for
inducing bone formation. Nat Biotechnol 2001; 19(4):332-5.
54. Athanasiou KA, Korvick D, Schenk RC. Biodegradable implants for the treatment of osteochon-
dral defects in a goat model. Tissue Engineering 1997; 3:363-74.
55. Zhao X, Harris JM. Novel degradable poly(ethylene glycol) hydrogels for controlled release of pro-
tein. J Pharm Sci 1998; 87(11):1450-8.
56. Peppas NA, Keys KB, Torres-Lugo M et al. Poly(ethylene glycol)-containing hydrogels in drug
delivery. J Control Release 1999; 62(1-2):81-7.
57. Elisseeff J, McIntosh W, Fu K et al. Controlled-release of IGF-I and TGF-beta1 in a
photopolymerizing hydrogel for cartilage tissue engineering. J Orthop Res 2001; 19(6):1098-104.
58. Richardson TP, Peters MC, Ennett AB et al. Polymeric system for dual growth factor delivery. Nat
Biotechnol 2001; 19(11):1029-34.
59. Otani K, Nita I, Macaulay W et al. Suppression of antigen-induced arthritis in rabbits by ex vivo
gene therapy. J Immunol 1996; 156(9):3558-62.
60. Le CH, Nicolson AG, Morales A et al. Suppression of collagen-induced arthritis through
adenovirus-mediated transfer of a modified tumor necrosis factor alpha receptor gene. Arthritis
Rheum 1997; 40(9):1662-9.
61. Makarov SS, Olsen JC, Johnston WN et al. Suppression of experimental arthritis by gene transfer
of interleukin 1 receptor antagonist cDNA. Proc Natl Acad Sci USA 1996; 93(1):402-6.
62. Evans CH, Ghivizzani SC, Lechman ER et al. Lessons learned from gene transfer approaches.
Arthritis Res 1999; 1(1):21-4.
63. Kozarsky KF, Wilson JM. Gene therapy: Adenovirus vectors. Curr Opin Genet Dev 1993;
3(3):499-503.
64. Gorecki DC, MacDermot KD. Gene therapy: Panacea or placebo? II. Main applications of gene
therapy. Arch Immunol Ther Exp (Warsz) 1997; 45(5-6):375-81.
65. Ghivizzani SC, Lechman ER, Kang R et al. Direct adenovirus-mediated gene transfer of interleukin
1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has
local and distal anti-arthritic effects. Proc Natl Acad Sci USA 1998; 95(8):4613-8.
66. Nita I, Ghivizzani SC, Galea-Lauri J et al. Direct gene delivery to synovium. An evaluation of
potential vectors in vitro and in vivo. Arthritis Rheum 1996; 39(5):820-8.
67. Roessler BJ, Allen ED, Wilson JM et al. Adenoviral-mediated gene transfer to rabbit synovium in
vivo. J Clin Invest 1993; 92(2):1085-92.
68. Evans C, Goins WF, Schmidt MC et al. Progress in development of herpes simplex virus gene
vectors for treatment of rheumatoid arthritis. Adv Drug Deliv Rev 1997; 27(1):41-57.